Press Release

Baylis Medical Launches 2-French Electrophysiology Catheter in Canada for Deeper Coronary Sinus Mapping

December 15, 2020

TORONTO, DECEMBER 15, 2020 – Baylis Medical announced today the Canadian launch of its EPstar Electrophysiology Catheters. The launch enables physicians to reach previously inaccessible areas of the heart for procedure mapping, by making available the smallest diagnostic catheter in the Canadian electrophysiology market.

The EPstar catheter family includes a 2F catheter and a 6F guiding catheter which can be combined to allow deeper coronary sinus (CS) mapping. Deeper electrophysiological examination, including mapping, is often required to aid in the diagnosis of idiopathic ventricular tachycardias, complex atrial tachycardias, and left Wolff-Parkinson-White Syndrome. The 2F catheter also allows mapping and pacing in smaller anatomy such as the Vein of Marshall (VOM).

The first Canadian case using the EPstar 2F catheter was performed by Dr. Benedict Glover, electrophysiologist at Sunnybrook Health Sciences Centre, in Toronto, Ontario.

“The small, tortuous branches of the coronary sinus often make it difficult to achieve accurate diagnosis for a number of more complex arrythmias,” said Dr. Glover. “Being the smallest diagnostic catheter available in Canada, the 2F catheter enables much-needed access into these branches for more accurate diagnosis, to therefore determine the best course of therapy for the patient.”

The 2F catheter features a flexible, atraumatic tip, and low energy pacing from the distal electrode. It can be delivered through any venous access point, enabling physicians to tailor their procedure to patient anatomy.

The 6F guiding catheter features two electrode spacing options to tailor the devices to a given procedure and includes a fully braided shaft, providing physicians with greater torque control. The 6F catheter also includes a lumen to allow visualization of coronary sinus anatomy, and is inserted via superior vein access.

The EPstar catheters are launched in partnership with Japan Lifeline (JLL), a leading Japanese cardiovascular device developer and manufacturer. The EPstar catheters are widely used in the Japanese electrophysiology market and were launched in the United States market in 2019.

To learn more about the EPstar catheter family, click here. 

 


About Baylis Medical
Baylis Medical is a leader in the development and commercialization of innovative cardiology devices that enable life-saving therapies. Headquartered in Canada, and with offices world-wide, our clinical solutions have been Improving the Lives of People Around the World for over 30 years. For more information, visit www.baylismedical.com and connect with us on Twitter, LinkedIn and Instagram.

About Japan Lifeline

Japan Lifeline is a manufacturer and importer of medical devices specializing in the cardiovascular space with a track record of about 40 years in Japan. The company’s proprietary products developed based on its wealth of experience of arrhythmias and cardiovascular surgery have been highly evaluated, and the company holds a top-class market share in Japan. Japan Lifeline is a publicly traded company, ticker symbol 7575 (TSE 1st Section). Visit the Japan Lifeline’s website at: http://www.japanlifeline.com


PRM-00674 EN J-2 V-1 © Baylis Medical Company Inc., 2020. The Baylis Medical logo is a trademark and/or registered trademarks of Baylis Medical Company Inc. in the USA and/or other countries. Other trademarks are property of their respective owners. CAUTION: Federal Law (USA) restricts the use of these devices to or by the order of a physician. Before use, consult product labels and Instructions for Use for Indications for Use, Contraindications, Warnings, Precautions, Adverse Event

Media Contact

media@baylismedical.com